NuvaRing is a vaginal ring birth control implant developed by Dutch pharmaceutical company Organon and now sold by Merck & Co. The device was approved by the FDA in 2001 and has been used by millions of women since as an alternative to birth control pills.
NuvaRing was marketed as a safe and convenient method of birth control with fewer side effects than oral contraceptives. Instead of daily use, it is inserted in the vagina once every three weeks and contains lower doses of chemical hormones.
Unfortunately, NuvaRing has now been linked to serious health risks. Studies show that the constant and direct release of hormones into the bloodstream can increase the risk of blood clots and serious conditions like pulmonary embolism, DVT and stroke.
So far, the FDA has received more than 1,000 reports of women suffering blood clot related injury or death while using NuvaRing.
Due to the number of affected patients filing NuvaRing lawsuits, the cases have been consolidated in a special federal multi-district litigation court in Missouri. Trials are scheduled to start in early 2013 and lawyers are helping those injured file claims.
If you or a loved one suffered a blood clot, pulmonary embolism, DVT or stroke after using NuvaRing, it is important to speak with a lawyer about your legal options. Contact us today for more information.
Researchers have discovered that the chemical hormones in vaginal ring contraceptives like NuvaRing can greatly increase the risk of blood clots and other harmful side effects.
In October of 2011, the FDA published research warning that vaginal ring contraceptives can increase the risk of blood clots, DVT and pulmonary embolism by as much as 56% over traditional low-dose estrogen birth control pills.
On May 10, 2012, the British Medical Journal published a study from Denmark which showed vaginal rings like NuvaRing could have as much as a 90% increased risk of blood clots over oral contraceptives.
The New England Journal of Medicine also published a study on June 14, 2012 finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.
Experts claim that documents recently unsealed in the NuvaRing litigation may show that Merck knew of these blood clot risks but failed to properly warn patients. The company now faces thousands of lawsuits by women and families which were affected.
Defective drug lawsuits can be complex legal matters. Before choosing a lawyer, make sure they are qualified to handle this type of case, have experience fighting large drug companies, and have the resources to finish your case.
The DrugRisk Resource Center works with only the top defective drug law firms in the country to make sure your case is handled properly and you recover quickly.
Contact us today for more information on the side effects, research and litigation related to NuvaRing, or to speak with a lawyer. We are available 24 hours a day to provide help.
Authored by Chris Schroeder